The North America agricultural biologicals market was valued at USD 5.46 billion in 2025. This market is expected to reach USD 24.5 billion by 2036, growing from USD 6.25 billion in 2026, at a CAGR of 14.6% from 2026 to 2036.

The market covers biological crop inputs derived from living organisms and natural materials, including biopesticides for crop protection, biostimulants for plant growth and stress tolerance, and biofertilizers and microbial inoculants for nutrient efficiency. Demand is driven by the growth of sustainable and regenerative agriculture, by integrated pest management and pesticide-resistance concerns, by regulation and residue limits on synthetic chemicals, by demand for organic and residue-free food, and by the cost of synthetic fertilizer. The United States accounts for the large majority of regional demand, and biopesticides are the largest product category. North America is the largest regional market globally, holding about a third of world demand.

Key Highlights – North America Agricultural Biologicals Market

• The North America agricultural biologicals market is expected to reach USD 24.5 billion by 2036, at a CAGR of 14.6% from 2026 to 2036, driven by sustainable agriculture, integrated pest management, and regulation of synthetic chemicals.
• North America leads global demand. North America held about 31.8% of the global agricultural biologicals market in 2025, the largest regional share, on early adoption of biological crop protection and nutrition.
• Biopesticides are the largest category. Biopesticides accounted for about 56.7% of the agricultural biologicals market in 2025, and crop nutrition solutions, including biofertilizers and biostimulants, claimed about 54.62% of the North American market, with biostimulants the fastest-growing segment.
• Biofertilizers cut synthetic fertilizer use. Biofertilizers that fix nitrogen or solubilise phosphate can reduce synthetic fertilizer use by up to 25%, giving growers immediate cost savings amid input-price volatility.
• Major companies are scaling biologicals. Corteva reported biologicals revenue of about USD 476 million in 2024, roughly 6.5% of its crop protection business, and Bayer, BASF, Syngenta, and FMC have expanded through acquisitions and partnerships.
• Consolidation and regulation advanced in 2026. In January 2026, BASF Agricultural Solutions agreed to acquire biological insect-control company AgBiTech, and in February 2026 the U.S. EPA proposed registration of new biopesticides including a plant-defense peptide and a broad-spectrum biofungicide.
• Key companies include Bayer AG, BASF SE, Syngenta Group, Corteva, Inc., and UPL Limited.

Report Overview

The North America agricultural biologicals market covers biological crop inputs derived from living organisms and natural materials, grouped into biopesticides for crop protection, biostimulants for plant growth and stress tolerance, and biofertilizers and microbial inoculants for nutrient efficiency. Biopesticides include microbial, botanical, biochemical, and semiochemical products and beneficial organisms; biostimulants include humic and fulvic acids, seaweed extracts, amino acids, and microbial products; and biofertilizers include nitrogen-fixing, phosphate-solubilizing, and mycorrhizal inoculants. Products are applied through foliar spray, seed treatment, soil treatment, and post-harvest use across cereals, oilseeds and pulses, fruits and vegetables, and other crops. Demand is concentrated in the United States, and the market is shaped by sustainability goals, integrated pest management, regulation, and fertilizer economics. This report examines the size, drivers, segmentation, countries, pricing, competition, recent developments, and outlook of the market, and provides recommendations for participants. Sizing is built bottom-up from crop acreage, adoption rates, and product-level demand.

Key Market Dynamics

Market Drivers

The main drivers of the North America agricultural biologicals market are sustainable and regenerative agriculture, integrated pest management and pesticide-resistance concerns, and regulation and residue limits on synthetic chemicals. Sustainable and regenerative agriculture is expanding demand for biological inputs across crop protection and nutrition, and North America's early adoption gives it about 31.8% of the global market. Integrated pest management and resistance are strong drivers in crop protection, as biopesticides offer modes of action that help manage resistance and meet residue limits, and biopesticides are already the largest category at about 56.7% of the market. Regulation and residue limits on synthetic pesticides, together with demand for organic and residue-free food, push growers toward biologicals. Fertilizer economics add a further driver, since biofertilizers that fix nitrogen or solubilise phosphate can cut synthetic fertilizer use by up to 25%, giving immediate cost savings. These factors, sustainable agriculture, integrated pest management, and regulation, are the main drivers.

Key Opportunities

The market offers opportunities in biopesticides for specialty and row crops, in biostimulants for stress tolerance, and in biologicals delivered through seed treatment. Biopesticides are the largest opportunity, because they address resistance management and residue limits across both high-value specialty crops and large-acreage row crops, and new active ingredients continue to reach the market through EPA registration. Biostimulants are the fastest-growing segment, expected to grow at about 11.9% in North America, offering nutrient-efficiency and stress-tolerance benefits that suit climate variability and input-cost pressure. Biologicals delivered through seed treatment are a high-growth application, integrating inoculants and biocontrol into standard planting practice on large acreage. These areas, biopesticides, biostimulants, and seed-treatment delivery, are the main opportunities, alongside biofertilizers for nutrient efficiency and post-harvest biocontrol.

Market Trends

Current trends include consolidation through acquisitions and partnerships, the expansion of major-company portfolios, regulatory streamlining, and the integration of biologicals into conventional programs. Consolidation is concentrating the field, with major agrochemical companies acquiring biocontrol and biologicals specialists, illustrated by the January 2026 agreement of BASF to acquire AgBiTech. The major companies are expanding biologicals within their broad crop-input portfolios, and Corteva, Bayer, Syngenta, and FMC have added products through acquisitions and partnerships. Regulation is streamlining, with the EPA proposing faster registration review for low-risk biopesticides and advancing new active ingredients in 2026. Biologicals are increasingly integrated with conventional crop protection and nutrition in combined programs rather than sold as standalone alternatives. These trends indicate a market moving into the mainstream of crop inputs.

Report Summary

Segmental Analysis

Market by Product Type

By product type, the market comprises biopesticides, biostimulants, and biofertilizers. Biopesticides hold the largest share, at about 57% of the market in 2026, with the remaining share divided between biostimulants and biofertilizers. Biopesticides, including microbial products such as Bacillus thuringiensis, botanical and biochemical products, semiochemicals such as pheromones, and beneficial organisms, are the largest category because they address pest control, resistance management, and residue limits across crops. Biostimulants, including humic and fulvic acids, seaweed extracts, amino acids, and microbial products, improve plant growth, nutrient efficiency, and stress tolerance, and are the fastest-growing segment. Biofertilizers, including nitrogen-fixing, phosphate-solubilizing, and mycorrhizal inoculants, improve nutrient availability and can reduce synthetic fertilizer use. Together, crop-nutrition products, biostimulants and biofertilizers, account for a large share of North American demand.

Market by Source

By source, the market comprises microbial, biochemical and natural, and macrobial products. Microbial products, based on bacteria, fungi, and viruses, are the largest and most versatile source, spanning biopesticides, biostimulants, and biofertilizers, and include microbial insecticides, fungicides, and inoculants. Biochemical and natural products, including botanical extracts, semiochemicals such as pheromones, humic substances, and seaweed extracts, serve crop protection and biostimulant uses. Macrobials, including beneficial insects and mites used for biological control, serve specialty and protected crops. Microbial products dominate because of their breadth of function and their fit with seed treatment and large-acreage application, while biochemical and macrobial products serve specific crop-protection needs.

Market by Application

By application, the market comprises foliar spray, seed treatment, soil treatment, and post-harvest use. Foliar spray holds the largest share, at about 45% of the market in 2026, with the remaining share divided across seed treatment, soil treatment, and post-harvest use. Foliar application is the most established method for biopesticides and biostimulants across crops. Seed treatment is a high-growth application, integrating biofertilizers, biocontrol, and biostimulants into standard planting practice on large-acreage row crops. Soil treatment, including in-furrow and broadcast application, delivers inoculants and biocontrol to the root zone. Post-harvest use applies biocontrol to protect stored and shipped produce. The growth of seed treatment reflects the integration of biologicals into mechanised planting.

Market by Crop Type

By crop type, the market comprises fruits and vegetables, cereals and grains, oilseeds and pulses, and other crops. Fruits and vegetables hold the largest share, at about 35% of the market in 2026, with the remaining share divided across cereals and grains, oilseeds and pulses, and other crops. Fruits and vegetables are the leading crop segment because their high value, residue sensitivity, and export requirements favour biopesticides and biostimulants, and specialty-crop growers were early adopters. Cereals and grains, led by corn and wheat, are a large and growing segment as biologicals scale on row crops. Oilseeds and pulses, led by soybean, use inoculants and biocontrol. Other crops, including turf, ornamentals, and specialty production, complete the segment.

Geographic Analysis

United States Agricultural Biologicals Market

The United States is by far the largest market in the region, accounting for the large majority of demand and underpinning North America's roughly 31.8% share of the global market. Demand spans specialty crops in California and other regions, where fruits and vegetables favour biopesticides and biostimulants, and row crops in the Midwest, where corn and soybean growers integrate biologicals into seed treatment and crop programs. Supply is led by Bayer AG, BASF SE, Syngenta Group, Corteva, Inc., UPL Limited, and FMC Corporation, alongside specialists such as Certis Biologicals, Valent BioSciences, Koppert, and Vestaron, and the EPA registration pathway supports new biopesticide active ingredients. The United States sets the pace for adoption, product development, and regulation across the region.

Canada Agricultural Biologicals Market

Canada is a significant secondary market with large row-crop and specialty-crop production, strong sustainability and pesticide-reduction policy, and established use of inoculants in pulses and soybean. Demand is driven by biopesticides and biostimulants in fruits, vegetables, and field crops, and by biofertilizers in the Prairie provinces. Supply is drawn from the same multinational and specialist companies active in the United States, and Canadian growers and agronomy networks support adoption. The country's large agricultural base and policy environment support steady growth.

Pricing Analysis

Pricing in agricultural biologicals is shaped by product type, performance, and the value of the synthetic inputs they complement or replace. Biopesticides and biostimulants are priced against conventional crop protection and nutrition, and their value rests on efficacy, residue and resistance benefits, and fit with integrated programs; they are often used alongside conventional products rather than as full replacements, which shapes how they are priced and adopted. Biofertilizers are priced against synthetic fertilizer, with their value tied to the fertilizer they displace, up to about 25% in nitrogen and phosphate.

Several factors set price. Product type and function are central, with specialty biopesticides and high-value biostimulants commanding premiums and commodity inoculants priced competitively. Performance and evidence increasingly determine price and adoption, since growers evaluate biologicals on efficacy and return, and variability in field performance is a consideration. Crop and value matter, with high-value fruits and vegetables supporting higher prices and large-acreage row crops favouring volume pricing. Regulatory approval affects market access and cost recovery. Scale, consolidation, and integration into major-company portfolios influence pricing, and the benchmark of synthetic crop protection and fertilizer sets the value against which biologicals are measured, so regulation and input-cost pressure strengthen the case for biologicals.

Competitive Landscape

The competitive field is led by large agrochemical companies that have built biologicals businesses alongside a base of specialists. Among the majors, Bayer AG, BASF SE, Syngenta Group, Corteva, Inc., UPL Limited, and FMC Corporation offer biopesticides, biostimulants, and biofertilizers within broad crop-input portfolios and have expanded through acquisitions and partnerships; Corteva reported biologicals revenue of about USD 476 million in 2024, and BASF agreed in January 2026 to acquire biological insect-control company AgBiTech. Novonesis, formed from Novozymes and Chr. Hansen, is a leading microbial supplier.

Among specialists, Certis Biologicals, Valent BioSciences LLC, a Sumitomo Chemical company, Koppert Biological Systems, and Vestaron Corporation provide biopesticides and biocontrol, and Bioceres Crop Solutions Corp. offers inoculants and biologicals. A wider field of biostimulant and biofertilizer producers serves crop nutrition. Competition turns on product efficacy and field evidence, regulatory approval, distribution and integration into crop programs, and breadth of portfolio, and the consolidation of specialists into major companies is concentrating capability. Companies that combine proven products, regulatory approval, distribution reach, and the ability to integrate biologicals into conventional programs are best positioned as the market moves into the mainstream of crop inputs.

Key Players

The active companies in the market as of September 2026 include:

• Bayer AG
• BASF SE
• Syngenta Group
• Corteva, Inc.
• UPL Limited
• FMC Corporation
• Novonesis (Novozymes A/S)
• Certis Biologicals
• Bioceres Crop Solutions Corp.
• Valent BioSciences LLC
• Koppert Biological Systems
• Vestaron Corporation

Voice of Customer

Specialty-crop grower (United States, California): "Residue limits and export requirements mean biologicals are part of every spray program now, not an alternative I try on the side. Biopesticides and biostimulants help me manage resistance and meet residue standards, and I use them in rotation with conventional products. What I need is consistent efficacy and clear guidance on how to fit them into the program."

Agronomist, farm retailer (United States, Midwest): "On corn and soybean, biologicals moved from a niche to a standard conversation, especially through seed treatment. Growers want field data and a clear return, whether it is a biofertilizer that cuts nitrogen or a biostimulant for stress. We recommend products with a track record and back them with local trial results."

Export horticulture manager (Mexico): "Our buyers set the residue and sustainability requirements, and biologicals are how we meet them while protecting the crop. Biopesticides and beneficial organisms are central to our program in protected agriculture. Reliability and compatibility with our existing practices matter most."

Analyst Perspective

North American agricultural biologicals is a large and fast-growing market moving into the mainstream of crop inputs. The region is the largest globally, with about a third of world demand, and growth is driven by durable forces: sustainable and regenerative agriculture, integrated pest management and resistance, regulation and residue limits, demand for organic and residue-free food, and fertilizer economics. Biopesticides are the largest category, biostimulants the fastest-growing, and biofertilizers offer clear cost savings against synthetic fertilizer, giving the market breadth across crop protection and nutrition.

The defining features of the market are integration and consolidation. Biologicals are increasingly used alongside conventional crop protection and nutrition in combined programs rather than as standalone alternatives, which supports adoption but ties biologicals to the broader crop-input market. Consolidation is concentrating capability, as major agrochemical companies acquire specialists, illustrated by the BASF acquisition of AgBiTech in 2026 and by the biologicals businesses built by Corteva, Bayer, Syngenta, and FMC. Field performance and evidence remain central, since biologicals are biological products whose results vary with conditions, and adoption depends on demonstrated efficacy and return. Regulatory approval through the EPA pathway is essential, and its streamlining supports new products. Companies that combine proven products, regulatory approval, distribution, and integration into crop programs are best positioned, and the market should be assessed on efficacy and adoption rather than on sustainability positioning alone.

Key Strategic Developments

• January 2026: BASF Agricultural Solutions agreed to acquire AgBiTech, a biological insect-control company using nucleopolyhedrovirus technology for corn, cotton, soybean, and specialty crops, with closing anticipated in the first half of 2026, marking a first major biologicals acquisition of the year and continuing consolidation.
• February 2026: The U.S. EPA proposed registration of new biopesticides, including the plant-defense peptide Ea peptide 91398, which activates natural plant defenses against bacterial and fungal infection, and a broad-spectrum biofungicide based on Priestia megaterium strain SYM36613, expanding the approved-active-ingredient base.
• 2026: Major companies including Corteva, Bayer, Syngenta, and FMC continued to expand biologicals within their portfolios, and seed treatment emerged as a high-growth application for biological crop inputs.
• 2025: Corteva reported biologicals revenue of about USD 476 million for 2024, roughly 6.5% of its crop protection business, and Syngenta launched the biological insecticide NETURE for soybean and corn, reflecting the scaling of biologicals by the majors.
• Through the first three quarters of 2026: Consolidation, portfolio expansion, and regulatory advancement continued to move agricultural biologicals into the mainstream of crop-input programs across North America.

Strategic Recommendations

For companies, the priority is to build proven, field-validated products and integrate them into crop-input programs, because biologicals are increasingly used alongside conventional crop protection and nutrition rather than as standalone alternatives, and adoption depends on demonstrated efficacy and return. Companies should strengthen portfolios across biopesticides, biostimulants, and biofertilizers, pursue EPA registration to bring new active ingredients to market, and integrate biologicals into seed treatment and combined programs. Consolidation offers a route to scale and distribution, as the acquisitions by the majors show, while specialists can compete on distinctive, proven technologies.

For growers and agronomists, the recommendation is to adopt biologicals on regional field evidence and return, integrating them into resistance-management and nutrient programs rather than treating them as a separate input, and to prioritise products with a track record and clear guidance on use. For policymakers, continued streamlining of the EPA registration pathway and support for integrated pest management would accelerate adoption of lower-risk inputs. For investors, this is a market to evaluate on product efficacy, regulatory approval, distribution reach, and integration into crop programs rather than on sustainability positioning alone, recognising that durable demand drivers and consolidation support growth while field performance and integration determine which products and companies succeed.